115 related articles for article (PubMed ID: 24996906)
1. In active juvenile dermatomyositis, elevated eotaxin and MCP-1 and cholesterol levels in the upper normal range are associated with cardiac dysfunction.
Schwartz T; Sjaastad I; Flatø B; Vistnes M; Christensen G; Sanner H
Rheumatology (Oxford); 2014 Dec; 53(12):2214-22. PubMed ID: 24996906
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of eotaxin and MCP-1 in juvenile dermatomyositis median 16.8 years after disease onset; associations with disease activity, duration and organ damage.
Sanner H; Schwartz T; Flatø B; Vistnes M; Christensen G; Sjaastad I
PLoS One; 2014; 9(3):e92171. PubMed ID: 24647150
[TBL] [Abstract][Full Text] [Related]
3. In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity.
Schwartz T; Sanner H; Gjesdal O; Flatø B; Sjaastad I
Ann Rheum Dis; 2014 Oct; 73(10):1805-10. PubMed ID: 23881732
[TBL] [Abstract][Full Text] [Related]
4. Novel associations between cytokines and pulmonary involvement in juvenile dermatomyositis - a cross-sectional study of long-term disease.
Marstein H; Schwartz T; Aaløkken TM; Lund MB; Flatø B; Sjaastad I; Sanner H
Rheumatology (Oxford); 2020 Aug; 59(8):1862-1870. PubMed ID: 31740970
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM
Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033
[TBL] [Abstract][Full Text] [Related]
6. In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset.
Barth Z; Nomeland Witczak B; Schwartz T; Gjesdal K; Flatø B; Koller A; Sanner H; Sjaastad I
Rheumatology (Oxford); 2016 Mar; 55(3):535-43. PubMed ID: 26500284
[TBL] [Abstract][Full Text] [Related]
7. Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.
Sanner H; Sjaastad I; Flatø B
Rheumatology (Oxford); 2014 Sep; 53(9):1578-85. PubMed ID: 24692575
[TBL] [Abstract][Full Text] [Related]
8. Adipokine profile in long-term juvenile dermatomyositis, and associations with adipose tissue distribution and cardiac function: a cross-sectional study.
Marstein HS; Witczak BN; Godang K; Olarescu NC; Schwartz T; Flatø B; Molberg Ø; Bollerslev J; Sjaastad I; Sanner H
RMD Open; 2023 Feb; 9(1):. PubMed ID: 36828644
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects.
Hashimoto I; Wada J; Hida A; Baba M; Miyatake N; Eguchi J; Shikata K; Makino H
Obesity (Silver Spring); 2006 May; 14(5):799-811. PubMed ID: 16855189
[TBL] [Abstract][Full Text] [Related]
11. Increased Eotaxin and MCP-1 Levels in Serum from Individuals with Periodontitis and in Human Gingival Fibroblasts Exposed to Pro-Inflammatory Cytokines.
Boström EA; Kindstedt E; Sulniute R; Palmqvist P; Majster M; Holm CK; Zwicker S; Clark R; Önell S; Johansson I; Lerner UH; Lundberg P
PLoS One; 2015; 10(8):e0134608. PubMed ID: 26241961
[TBL] [Abstract][Full Text] [Related]
12. Cardiac dysfunction in juvenile dermatomyositis: a case-control study.
Schwartz T; Sanner H; Husebye T; Flatø B; Sjaastad I
Ann Rheum Dis; 2011 May; 70(5):766-71. PubMed ID: 21216816
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary outcome in juvenile dermatomyositis: a case-control study.
Sanner H; Aaløkken TM; Gran JT; Sjaastad I; Johansen B; Flatø B
Ann Rheum Dis; 2011 Jan; 70(1):86-91. PubMed ID: 20805295
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial.
Loughrey BV; McGinty A; Young IS; McCance DR; Powell LA
Clin Endocrinol (Oxf); 2013 Dec; 79(6):800-6. PubMed ID: 23170936
[TBL] [Abstract][Full Text] [Related]
15. Serum chemokine profile in patients with bullous pemphigoid.
Nakashima H; Fujimoto M; Asashima N; Watanabe R; Kuwano Y; Yazawa N; Maruyama N; Okochi H; Kumanogoh A; Tamaki K
Br J Dermatol; 2007 Mar; 156(3):454-9. PubMed ID: 17300233
[TBL] [Abstract][Full Text] [Related]
16. Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
Berntsen KS; Tollisen A; Schwartz T; Kirkhus E; Aaløkken TM; Lund MB; Flatø B; Sjaastad I; Sanner H
J Rheumatol; 2017 Jun; 44(6):827-834. PubMed ID: 28365577
[TBL] [Abstract][Full Text] [Related]
17. Diastolic dysfunction in paediatric patients on peritoneal dialysis and after renal transplantation.
Ten Harkel AD; Cransberg K; Van Osch-Gevers M; Nauta J
Nephrol Dial Transplant; 2009 Jun; 24(6):1987-91. PubMed ID: 19225014
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
Mathiesen PR; Buchvald F; Nielsen KG; Herlin T; Friis T; Nielsen S
Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular diastolic dysfunction in patients with dermatomyositis without clinically evident cardiovascular disease.
Wang H; Liu HX; Wang YL; Yu XQ; Chen XX; Cai L
J Rheumatol; 2014 Mar; 41(3):495-500. PubMed ID: 24429180
[TBL] [Abstract][Full Text] [Related]
20. Body composition in long-standing juvenile dermatomyositis: associations with disease activity, muscle strength and cardiometabolic measures.
Witczak BN; Bollerslev J; Godang K; Schwartz T; Flatø B; Molberg Ø; Sjaastad I; Sanner H
Rheumatology (Oxford); 2022 Jul; 61(7):2959-2968. PubMed ID: 34718443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
